Coherus Oncology (CHRS) Gross Profit (2019 - 2026)
Coherus Oncology's Gross Profit was $10.07 million in Q2 2026, up 46.7% from $6.86 million a year earlier and up 18.5% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Gross Profit (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Coherus Oncology's Gross Profit was $35.11 million through Jun 30, 2026, up 74.6% year-over-year; for FY2025, it came in at $28.36 million, up 60.6% from FY2024.
- Gross Profit shows a five-year compound annual growth rate of -42.2% (FY2020 to FY2025).
- In earlier years, Gross Profit was $17.66 million in FY2024 (-82.0%), $98.25 million in FY2023 (-30.3%), $140.96 million in FY2022 (-47.6%) and $268.96 million in FY2021 (-38.6%).
- The Q2 2026 figure marks the highest quarterly Gross Profit since Q3 2023.
- Compared with a year earlier, Gross Profit has increased for four straight quarters, with growth averaging 82.4% over the last eight quarters.
- The best year-over-year quarter for Gross Profit over five years was Q1 2025 (growth of 469.2%); the worst was Q1 2024 (a decline of 94.4%).
- Per Business Quant data, CHRS's Gross Profit in the three quarters before Q2 2026 was $8.5 million (Q1 2026), $8.7 million (Q4 2025) and $7.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.54 Bn | 1,195.15 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 650.21 Bn | 570.07 Bn | 17.30 Bn |
| 3 | AbbVie | 508.24 Bn | 476.24 Bn | 13.12 Bn |
| 4 | Merck | 360.07 Bn | 323.01 Bn | 13.19 Bn |
| 5 | Novartis Ag | 312.26 Bn | 285.49 Bn | - |
| 6 | Astrazeneca | 285.31 Bn | 259.20 Bn | 13.26 Bn |
| 7 | Amgen | 247.74 Bn | 199.39 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.12 Bn | 182.22 Bn | 6.73 Bn |
| 9 | Pfizer | 166.13 Bn | 113.48 Bn | 12.56 Bn |
| 10 | Coherus Oncology | 116.17 Mn | -519.97 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.07 Mn |
| Mar 31, 2026 | 8.50 Mn |
| Dec 31, 2025 | 8.70 Mn |
| Sep 30, 2025 | 7.85 Mn |
| Jun 30, 2025 | 6.86 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | 8.49 Mn |
| Mar 31, 2024 | 869,000.00 |
| Dec 31, 2023 | 6.96 Mn |
| Sep 30, 2023 | 41.87 Mn |
| Jun 30, 2023 | 33.87 Mn |
| Mar 31, 2023 | 15.56 Mn |
| Dec 31, 2022 | 31.15 Mn |
| Sep 30, 2022 | 10.19 Mn |
| Jun 30, 2022 | 48.87 Mn |
| Mar 31, 2022 | 50.75 Mn |
| Dec 31, 2021 | 61.25 Mn |
| Sep 30, 2021 | 61.22 Mn |
API Access
Coherus Oncology Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();